Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States.

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic.

Prevalence and predictors of SARS-CoV-2 antibodies among solid organ transplant recipients with confirmed infection.

Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.

Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic

COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.

Travel Medicine and Transplant Tourism in Solid Organ Transplantation

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.

COVID-19 in Kidney Transplantation: Outcomes, Immunosuppression Management, and Operational Challenges.

Underimmunization of the solid organ transplant population: An urgent problem with potential digital health solutions.

Strategies for liver transplantation during the SARS-CoV-2 outbreak: Preliminary experience from a single center in France.

Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.

Management of lung transplantation in the COVID-19 era-An international survey.

Aspergillosis in Solid Organ Transplantation

A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients.